Business Standard

Coronavirus fears lead to sudden spike in pneumonia vaccine sales

many people have become sensitised to adult vaccination in the country as we await the first vaccine candidate against the SARS-CoV-2 virus

Coronavirus testing
Premium

Pune’s Serum Institute recently got the regulator’s nod to market its indigenously made PCV in India

Sohini Das Mumbai
Anit Roychowdhury (name changed) took a pneumonia shot in his office along with his colleague. Roychowdhury works for a pharma company in Mumbai and has been going to work during the lockdown. He says that they never felt the need to get themselves vaccinated against either flu or pneumonia. However, it was the coronavirus (Covid-19) pandemic that woke them up to the need to protect themselves against respiratory illnesses.

Many like Roychowdhury have become sensitised to adult vaccination in the country as we await the first vaccine candidate against the SARS-CoV-2 virus.
 
As such, there has been a sudden spike

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in